You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity

Article metrics

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity

 

Online download statistics by month:

Online download statistics by month: August 2020 to March 2026

AbstractFullPdf
Aug 202015150
Sep 2020385385186
Oct 202010410429
Nov 2020626240
Dec 2020565621
Jan 2021636332
Feb 2021646428
Mar 2021797957
Apr 2021545418
May 2021717138
Jun 2021595956
Jul 2021555586
Aug 2021363690
Sep 202117217259
Oct 2021606044
Nov 2021707052
Dec 2021373720
Jan 2022384133
Feb 2022354121
Mar 2022727822
Apr 2022485121
May 2022586627
Jun 2022676925
Jul 2022576422
Aug 2022959725
Sep 2022697453
Oct 2022606629
Nov 2022585917
Dec 202231329
Jan 2023454516
Feb 2023434310
Mar 2023323526
Apr 2023494941
May 2023394020
Jun 2023404435
Jul 2023282819
Aug 2023323214
Sep 2023434425
Oct 2023464617
Nov 2023505111
Dec 2023595921
Jan 2024323321
Feb 202423237
Mar 2024535351
Apr 2024777936
May 2024384218
Jun 2024505024
Jul 2024434416
Aug 2024262616
Sep 2024343419
Oct 2024575936
Nov 2024474830
Dec 2024495114
Jan 2025484827
Feb 202511011226
Mar 2025464722
Apr 2025696924
May 2025535436
Jun 2025373824
Mar 2026110
Total352936071862